Antimicrobial Resistance in Staphylococci - 25/05/16
Résumé |
Staphylococci have developed a variety of strategies for dealing with the presence of antibiotics encountered in clinical environments. Resistance to β-lactams and other antimicrobial agents has been accomplished by a diverse array of molecular mechanisms. Options available to treat infections caused by staphylococci resistant to methicillin are limited, and the next generation of antibiotics to be introduced, should glycopeptide resistance become an important clinical problem, is not yet on the horizon.
Le texte complet de cet article est disponible en PDF.| Dr. Moreira is supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil. Address reprint requests to: Robert S. Daum, MD, CM, Wyler Children's Hospital MC 6054, 5841S. Maryland Avenue, Chicago, IL 60637 |
Vol 42 - N° 3
P. 619-648 - juin 1995 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
